Clean

Incentivizing diverse representation in clinical trials

Published Mar 2, 2022, 6:42 PM

Diverse representation in clinical trials is critical in achieving greater equity and better healthcare outcomes. DLA Piper's Kirsten Axelsen and Sarah Schick are joined by Shazia Ahmad, Senior Director and Head of Patient and Physician Services at UBC, to discuss the importance of regulatory incentives to drive racial and ethnic diversity in clinical trials.

At the Intersection of Science and Law

In DLA Piper’s At the Intersection of Science and Law podcast, members of the firm’s Life Sciences t 
Social links
Follow podcast
Recent clips
Browse 14 clip(s)